Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality? - Wikidata - wikimedia - TriplyDB

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

http://www.wikidata.org/entity/Q38776303

about

Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?

P2860

Q49894154-27F63B86-3505-4937-9479-9BF9FB322552

P2860

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

http://www.wikidata.org/entity/Q38776303

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

@en

type

label

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

@en

prefLabel

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

@en

P1433

Q38776303-459F59FF-C057-4FF7-88B2-809F358B7EC7

P1476

Q38776303-0EC42E69-B1A9-47D7-B353-3FEBB99D7062

P2093

Q38776303-6BD0BC78-03D4-45A3-94A4-6A2C56BAE796

Q38776303-96EF95B3-F227-4651-BB35-84C02F6F43A1

Q38776303-9989531D-8B3B-4E0C-8514-B9EA3E7285ED

P2860

Q38776303-1E8145AB-FA35-4B38-A471-2DA74AD54836

Q38776303-1F36E570-DD81-4E25-8D7A-E4803B4BD97C

Q38776303-3BAE9982-6E31-4D0A-9C19-8F0942B30D51

Q38776303-3DB0CD9F-A73F-4320-B33E-6646EF3FFB67

Q38776303-4EDB578E-29A3-483F-BA25-E99F0CE5C05D

Q38776303-57ED6D7A-935D-4E84-A408-7C32EA1C3175

Q38776303-7210A33E-9613-4953-9F83-968CEE557409

Q38776303-984E269E-3DDA-4910-8424-DB31559BB8D3

Q38776303-A62D41A1-6C25-49B6-82AB-02D227B58E4A

Q38776303-BB5363DF-0AEC-4BD1-BFD3-8C20C00BE9D5

P304

Q38776303-76CB35B2-AA70-460B-B629-93BFB05ABCB6

P31

Q38776303-6C934D07-3A80-4088-8907-786D26A7C62F

P356

Q38776303-C7A38379-744C-4D33-B50A-DCE6BCCE767F

P407

Q38776303-3035E966-A3C7-4A12-8673-5249E5378579

P433

Q38776303-A282A96F-1DD8-4CFE-B325-9203FF60E3CA

P478

Q38776303-3E92F4FD-0730-4962-90C3-F5FDEDB13F1C

P577

Q38776303-CC56480B-E61D-473E-BB46-2E936B00E05E

P698

Q38776303-CCC18D7E-D949-4DDD-B67D-A13CF75EBFD0

P921

Q38776303-019CC571-AC18-4DDA-8B97-1BFB418675A3

P932

Q38776303-E3101599-F9BC-4AF9-95D4-466B34795069

P356

J.YGYNO.2017.05.012

P1433

Gynecologic Oncology

P1476

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

@en

P2093

Emma L Barber

http://www.w3.org/2001/XMLSchema#string

Kemi M Doll

http://www.w3.org/2001/XMLSchema#string

Paola A Gehrig

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)

A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications.

Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program.

Risk factors and indications for 30-day readmission after primary surgery for epithelial ovarian cancer

A scoring system to predict unplanned intubation in patients having undergone major surgical procedures.

A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery

Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma.

Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma.

Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.

P304

368-372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2017.05.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28522108

http://www.w3.org/2001/XMLSchema#string

P921

P932

5614497

http://www.w3.org/2001/XMLSchema#string